Ankerstar Wealth’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Ankerstar Wealth's VIR Position: Q3 2026 in Review
Ankerstar Wealth held its Vir Biotechnology (VIR) position steady in Q3 2026 at 19 shares worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #924.
Ankerstar Wealth first reported a position in VIR in Q4 2025 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Ankerstar Wealth held 19 shares of Vir Biotechnology worth $212 as of Q3 2026.
- Ankerstar Wealth left its Vir Biotechnology share count unchanged in Q3 2026.
- Vir Biotechnology made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #924 holding.
- Ankerstar Wealth first reported a position in Vir Biotechnology in Q4 2025 and has held it in 4 quarters since.
- 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.